ReviewFrontiers in oncology2024

High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma.

Johannes Pöhlmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.